Skip to main content
. 2021 Jul 21;11:14903. doi: 10.1038/s41598-021-94547-0

Table 1.

Overall, MT rRT-PCR group and MT antigen group participant demographics.

Categories Overall (N = 325) MT rRT-PCR (N = 178) MT antigen (N = 147)
Total, n (%)
Adult 196 (60.3%) 100 (56.2%) 96 (65.3%)
Pediatric 129 (39.7%) 78 (43.8%) 51 (34.7%)
Age, years
Mean (min–max) 33.1 (0.1–82.6) 32.1 (0.1–82.6) 34.3 (0.4–78.3)
Median (25th–75th) 33.6 (9.3–54.8) 28.8 (9.5–55.2) 36.8 (9.0–54.2)
Gender, n (%)
Male 164 (50.5%) 91 (51.1%) 73 (49.7%)
Female 161 (49.5%) 87 (48.9%) 74 (50.3%)
Race, n (%)
White 110 (33.8%) 69 (38.8%) 41 (27.9%)
Black/African American 164 (50.5%) 81 (45.5%) 83 (56.5%)
Asian 17 (5.2%) 12 (6.7%) 5 (3.4%)
Other 34 (10.5%) 16 (9.0%) 18 (12.2%)
Ethnicity, n (%)
Hispanic 44 (13.5%) 24 (13.5%) 20 (13.6%)
Non-hispanic 281 (86.5%) 154 (86.5%) 127 (86.4%)
Days post-symptom onset
Mean (min–max) 3.5 (0.0–7.0) 3.4 (0.0–7.0) 3.6 (0.0–7.0)
Median (25th–75th) 3.0 (2.0–5.0) 3.0 (2.0–5.0) 3.0 (2.0–5.0)
NP result, n (%)
Positive 128 (39.4%) 74 (41.6%) 54 (36.7%)
Negative 197 (60.6%) 104 (58.4%) 93 (63.3%)

Missing: n = 1 for race/ethnicity (refused to answer).